Establishment Labs Holdings Inc (ESTA) has released an update.
Establishment Labs Holdings Inc. has revised its credit agreement with Oaktree Fund Administration, extending the deadline for Tranche C and D Term Loans and increasing the interest rate from 9% to 10% per annum. The amendment also alters the prepayment premium structure and modifies the milestones for loan availability, tying the release of Tranche C funds to FDA approval for Motiva Implants and reducing the sales target for Tranche D. These strategic financial adjustments aim to bolster the company’s position in the market.
For further insights into ESTA stock, check out TipRanks’ Stock Analysis page.
